C3 Glomerulopathy
Reference76 articles.
1. Nasr SH, Valeri AM, Appel GB, Sherwinter J, Stokes MB, Said SM, et al. Dense deposit disease: Clinicopathologic study of 32 pediatric and adult patients. Clinical Journal of the American Society of Nephrology. 2009;4:22-32
2. Servais A, Noël LH, Roumenina LT, Le Quintrec M, Ngo S, Dragon-Durey MA, et al. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney International. 2012;82:454-464
3. Bomback AS, Santoriello D, Avasare RS, Regunathan-Shenk R, Canetta PA, Ahn W, et al. C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy. Kidney International. 2018;93:977-985
4. Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis: Pathogenetic heterogeneity and proposal for a new classification. Seminars in Nephrology. 2011;31:341-348
5. Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis—A new look at an old entity. The New England Journal of Medicine. 2012;366:1119-1131